查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1706139

2025年全球基层医疗即时诊断市场报告

Primary Care POC Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年基层医疗POC 诊断市场规模将强劲成长。到 2029 年，这一数字将成长至 238.6 亿美元，年复合成长率（CAGR）为 7.6%。预测期内的增长可以归因于感染疾病爆发的出现、非传染性疾病应用的不断增长、家庭医疗保健环境中的日益普及、精准医疗计划的增长、医疗保健基础设施投资的增加、疾病负担的增加以及对早期发现疾病重要性的认识的提高。预测期内的关键趋势包括人工智慧 (AI) 和机器学习演算法的整合、分子诊断技术的进步、POC 诊断设备的小型化和便携性、智慧型装置的整合以及在 POC 诊断中使用多路復用和麵板测试。

预计感染疾病的增加可能会在短期内推动基层医疗POC 诊断市场的成长。感染疾病是由细菌、病毒、真菌或寄生虫等致病微生物引起的，透过直接或间接接触受污染的表面、空气、水或昆虫等媒介传播。导致其传播的因素包括恶劣的环境条件、都市化、抗生素抗药性和疫苗接种不足。基层医疗POC 诊断在应对这一日益严重的感染疾病发挥关键作用，它能够在一系列医疗保健环境中实现早期发现、及时治疗和有效的疾病管理。例如，2023 年 10 月，英国卫生安全局的报告显示，英国的爱滋病毒诊断人数将从 2021 年的 3,118 人增加 22% 至 2022 年的 3,805 人。此外，2023 年 11 月，世界卫生组织 (WHO) 报告称，2022 年全球约有 1,060 万例结核病病例，影响到不同人群的数百万人。因此，感染疾病的激增正在推动基层医疗POC 诊断市场向前发展。

基层医疗POC 诊断市场的主要企业正专注于携带式照护现场RT-PCR 系统等先进技术解决方案，以优化市场收益。这些系统专为在传统实验室外进行即时逆转录聚合酵素链锁反应(RT-PCR) 测试而设计，具有移动性和紧凑性。例如，Genes2Me Pvt。有限公司于 2022 年 10 月推出了其 Rapi-Q 即时检验 RT PCR 解决方案。 Rapi-Q 系统可携式且重量轻，适用于医院、血库、诊所、实验室和机场等各种环境。它具有高灵敏度、高准确度、高效能，并相容于50多种冷冻干燥、常温保存的疾病检测套件。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球基层医疗POC 诊断 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球基层医疗POC诊断市场：成长率分析
  • 全球基层医疗POC 诊断市场表现：规模与成长，2019-2024 年
  • 全球基层医疗POC 诊断市场预测：规模与成长，2024-2029 年，2034 年预测
  • 全球基层医疗POC 诊断总目标市场 (TAM)

第六章市场区隔

  • 全球基层医疗POC 诊断市场（按产品、绩效和预测）2019-2024 年、2024-2029 年、2034 年
  • 血糖监测
  • 心臟代谢测试产品
  • 传染病检查产品
  • 血液凝固检验产品
  • 妊娠和生育测试产品
  • 肿瘤或癌症标记检测产品
  • 胆固醇检测产品
  • 血液检测产品
  • 药物滥用（DOA）检测产品
  • 其他产品
  • 全球基层医疗POC 诊断市场（处方笺、实际及预测），2019-2024 年、2024-2029 年、2034 年
  • 处方笺
  • 非处方药（OTC）检测
  • 全球基层医疗POC 诊断市场（按最终用途、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断中心
  • 研究部门
  • 居家照护环境
  • 其他用途
  • 全球基层医疗POC 诊断市场、血糖监测细分市场（按类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 血糖测量装置
  • 持续血糖监测（CGM）系统
  • 血糖值试纸
  • 血糖控制解决方案
  • 全球基层医疗POC 诊断市场心臟代谢检测产品类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 血压计
  • 血脂检测套组
  • 糖化血红素 A1c检测套组
  • 心电图或心电图监测仪
  • Hba1c照护现场设备
  • 全球基层医疗POC 诊断市场传染病检查产品类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 链球菌快速检测
  • 流感检测套组
  • COVID-19快速检测
  • HIV快速检测套组
  • 肝炎检测套组
  • 疟疾快速诊断检测（RDTS）
  • 其他传染病检查
  • 全球基层医疗POC 诊断市场血液凝固检验产品类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 凝血酶原时间（Pt）检测套组
  • 国际标准化比率（INR）监测器
  • 活化部份凝血活酵素时间（Aptt）检测套组
  • 凝血控制解决方案
  • 全血凝固监测仪
  • 全球基层医疗POC 诊断市场、怀孕及不孕症检测产品类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 家庭妊娠测试（尿液检查）
  • 排卵预测试剂套件
  • 妊娠试纸
  • 妊娠监测设备
  • 全球基层医疗POC 诊断市场按肿瘤或癌症标记检测产品类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • PSA（前列腺特异性抗原）检测套组
  • Cea（癌胚抗原）检测套组
  • Ca-125（卵巢癌标记）套件
  • Her2检测套组
  • 其他肿瘤标记检测套组
  • 全球基层医疗POC 诊断市场胆固醇检测产品类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 总胆固醇检测套组
  • LDL 或 HDL检测套组
  • 三酸甘油酯检测套组
  • 照护现场脂质检测装置
  • 全球基层医疗POC 诊断市场血液检测产品类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 血红素检测套组
  • 血球容积比检测套组
  • 全血球计数（CBC）套件
  • 照护现场血液分析仪
  • 糖化血红素 A1c 检测仪
  • 全球基层医疗POC 诊断市场细分（按药物滥用 (DOA) 检测产品类型、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 尿液药物检测
  • 口腔液体药物检测
  • 唾液药物检测
  • 血液药物检测
  • 呼气酒精测试
  • 全球基层医疗POC 诊断市场、其他产品细分、按类型、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 过敏检测套组
  • 尿液检查测试纸
  • 维生素和矿物质缺乏症检测套组
  • 照护现场肝功能检测
  • 肾功能检测产品
  • 血气检测设备

第七章 区域和国家分析

  • 全球基层医疗POC 诊断市场（按地区、绩效及预测）：2019-2024 年、2024-2029 年、2034 年
  • 全球基层医疗POC 诊断市场：按国家/地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 基层医疗POC 诊断市场：竞争格局
  • 基层医疗POC 诊断市场：公司简介
    • Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis
    • bioMerieux SA Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Quidel Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Nova Biomedical Corporation
  • Randox Laboratories Ltd
  • Ortho Clinical Diagnostics
  • Nipro Corporation
  • OraSure Technologies
  • Meridian Bioscience Inc
  • DiaSorin SpA
  • Sekisui Diagnostics LLC
  • EKF Diagnostics Holdings plc
  • Trinity Biotech plc
  • Fujirebio Diagnostics Inc.
  • Immunodiagnostic Systems Holdings PLC

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年基层医疗POC 诊断市场：提供新机会的国家
  • 2029 年基层医疗POC 诊断市场：细分市场带来新机会
  • 2029 年基层医疗POC 诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r31012

A point-of-care (POC) diagnostic in primary care entails conducting medical tests or evaluations conveniently and swiftly within a primary care environment, such as a doctor's office or clinic, without the need for specialized equipment or extensive laboratory processing. These diagnostics aim to deliver prompt results, enabling healthcare providers to make timely decisions regarding patient care during the initial consultation.

Primary care POC diagnostics encompass a range of products, including glucose monitoring, cardiometabolic testing products, infectious disease testing products, coagulation testing products, pregnancy and fertility testing products, tumor or cancer marker testing products, cholesterol testing products, hematology testing products, drug-of-abuse (DOA) testing products, among others. Glucose monitoring involves measuring blood glucose levels to manage diabetes and is available in different types such as prescription-based and over-the-counter (OTC) testing. These are utilized across various settings, including hospitals, diagnostic centers, research laboratories, home-care settings, and others.

The primary care POC diagnostics market research report is one of a series of new reports from The Business Research Company that provides primary care POC diagnostics market statistics, including primary care POC diagnostics industry global market size, regional shares, competitors with a primary care POC diagnostics market share, detailed primary care POC diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the primary care POC diagnostics industry. This primary care POC diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The primary care POC diagnostics market size has grown strongly in recent years. It will grow from $16.46 billion in 2024 to $17.78 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to the increasing prevalence of chronic diseases, shift towards personalized medicine, growing healthcare expenditure, rise in supportive regulatory frameworks and expedited approval processes, and growing emphasis on early disease detection and prevention strategies.

The primary care POC diagnostics market size is expected to see strong growth in the next few years. It will grow to $23.86 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to the emergence of infectious disease outbreaks, expanding applications in non-communicable diseases, increasing adoption in home healthcare settings, growth in precision medicine initiatives, rising healthcare infrastructure investments, increasing disease burden, and growing awareness of the importance of early disease detection. Major trends in the forecast period include the integration of artificial intelligence (AI) and machine learning algorithms, advancements in molecular diagnostics technologies, miniaturization and portability of POC diagnostic devices, integration of smart devices, and usage of multiplexing and panel testing in POC diagnostics.

The anticipated increase in infectious diseases is poised to drive the expansion of the primary care POC diagnostics market in the foreseeable future. Infectious diseases, caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, spread through direct or indirect contact with contaminated surfaces, air, water, or vectors such as insects. Factors contributing to their prevalence include poor environmental conditions, urbanization, antimicrobial resistance, and insufficient vaccination coverage. Primary care POC diagnostics play a crucial role in addressing this rise in infectious diseases by enabling early detection, timely treatment, and effective disease control across various healthcare settings. For example, in October 2023, a report from the UK Health Security Agency revealed a 22% increase in HIV diagnoses in England from 3,118 in 2021 to 3,805 in 2022. Additionally, in November 2023, the World Health Organization reported approximately 10.6 million cases of tuberculosis globally in 2022, affecting millions across different demographics. Thus, the surge in infectious diseases is propelling the primary care POC diagnostics market forward.

Leading companies in the primary care POC diagnostics market are concentrating on advanced technological solutions, such as portable point-of-care RT-PCR systems, to optimize their market revenue. These systems, designed for real-time reverse transcription polymerase chain reaction (RT-PCR) tests outside traditional laboratories, offer mobility and compactness. For instance, Genes2Me Pvt. Ltd. introduced the Rapi-Q Point of Care RT PCR solution in October 2022, featuring an eight-well block design with four fluorescent channels, claimed to deliver rapid results in under 45 minutes. Portable and lightweight, the Rapi-Q system is suitable for various settings such as hospitals, blood banks, health clinics, research laboratories, and airports. It boasts high sensitivity, accuracy, and performance in disease detection, compatible with over 50 lyophilized, room-temperature disease detection kits.

In July 2024, F. Hoffmann-La Roche Ltd., a Switzerland-based pharmaceutical company, acquired LumiraDx's point-of-care technology from LumiraDx for $350 million. With this acquisition, Roche aims to expand its diagnostic portfolio and enhance access to decentralized testing, particularly in primary care settings and low- to middle-income countries. LumiraDx is a UK-based point-of-care diagnostic company focused on transforming community-based healthcare.

Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

North America was the largest region in the primary care POC diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the primary care POC diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary care POC diagnostics market consists of sales of respiratory pathogen testing products, thyroid function testing products, electrolyte testing products, and liver function testing products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Primary Care POC Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on primary care poc diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for primary care poc diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The primary care poc diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Glucose Monitoring; Cardiometabolic Testing Products; Infectious Disease Testing Products; Coagulation Testing Products; Pregnancy And Fertility Testing Products; Tumor Or Cancer Marker Testing Products; Cholesterol Testing Products; Hematology Testing Products; Drug-Of-Abuse (DOA) Testing Products; Other Products
  • 2) By Prescription: Prescription Based; Over-The-Counter (OTC) Testing
  • 3) By End-Use: Hospitals; Diagnostic Centers; Research Laboratories; Home-Care Settings; Other End-Uses
  • Subsegments:
  • 1) By Glucose Monitoring: Blood Glucose Meters; Continuous Glucose Monitoring (Cgm) Systems; Test Strips For Glucose Meters; Glucose Control Solutions
  • 2) By Cardiometabolic Testing Products: Blood Pressure Monitors; Lipid Profile Testing Kits; Hemoglobin A1c Testing Kits; Ecg Or Ecg Monitors; Hba1c Point-Of-Care Devices
  • 3) By Infectious Disease Testing Products: Rapid Strep Tests; Influenza (Flu) Testing Kits; Covid-19 Rapid Tests; Hiv Rapid Testing Kits; Hepatitis Testing Kits; Malaria Rapid Diagnostic Tests (Rdts); Other Infectious Disease Tests
  • 4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits; International Normalized Ratio (Inr) Monitors; Activated Partial Thromboplastin Time (Aptt) Testing Kits; Coagulation Control Solutions; Whole Blood Coagulation Monitors
  • 5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based); Ovulation Prediction Kits; Pregnancy Test Strips; Fertility Monitoring Devices
  • 6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits; Cea (Carcinoembryonic Antigen) Testing Kits; Ca-125 (Ovarian Cancer Marker) Kits; Her2 Testing Kits; Other Tumor Marker Test Kits
  • 7) By Cholesterol Testing Products: Total Cholesterol Testing Kits; Ldl Or Hdl Testing Kits; Triglyceride Testing Kits; Point-Of-Care Lipid Panel Devices
  • 8) By Hematology Testing Products: Hemoglobin Test Kits; Hematocrit Testing Kits; Complete Blood Count (Cbc) Kits; Point-Of-Care Hematology Analyzers; Hemoglobin A1c Testing Devices
  • 9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests; Oral Fluid Drug Tests; Saliva-Based Drug Tests; Blood-Based Drug Tests; Breath Alcohol Tests
  • 10) By Other Products: Allergy Testing Kits; Urinalysis Test Strips; Vitamin And Mineral Deficiency Testing Kits; Point-Of-Care Liver Function Tests; Kidney Function Testing Products; Blood Gas Testing Devices
  • Companies Mentioned: Hoffmann-La Roche Ltd; Abbott Laboratories; Siemens Healthineers AG; Becton, Dickinson And Company; bioMerieux SA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Primary Care POC Diagnostics Market Characteristics

3. Primary Care POC Diagnostics Market Trends And Strategies

4. Primary Care POC Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Primary Care POC Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Primary Care POC Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Primary Care POC Diagnostics Market Growth Rate Analysis
  • 5.4. Global Primary Care POC Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Primary Care POC Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Primary Care POC Diagnostics Total Addressable Market (TAM)

6. Primary Care POC Diagnostics Market Segmentation

  • 6.1. Global Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glucose Monitoring
  • Cardiometabolic Testing Products
  • Infectious Disease Testing Products
  • Coagulation Testing Products
  • Pregnancy And Fertility Testing Products
  • Tumor Or Cancer Marker Testing Products
  • Cholesterol Testing Products
  • Hematology Testing Products
  • Drug-Of-Abuse (DOA) Testing Products
  • Other Products
  • 6.2. Global Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prescription Based
  • Over-The-Counter (OTC) Testing
  • 6.3. Global Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Research Laboratories
  • Home-Care Settings
  • Other End-Uses
  • 6.4. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Glucose Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Meters
  • Continuous Glucose Monitoring (Cgm) Systems
  • Test Strips For Glucose Meters
  • Glucose Control Solutions
  • 6.5. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Cardiometabolic Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Pressure Monitors
  • Lipid Profile Testing Kits
  • Hemoglobin A1c Testing Kits
  • Ecg Or Ecg Monitors
  • Hba1c Point-Of-Care Devices
  • 6.6. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Infectious Disease Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rapid Strep Tests
  • Influenza (Flu) Testing Kits
  • Covid-19 Rapid Tests
  • Hiv Rapid Testing Kits
  • Hepatitis Testing Kits
  • Malaria Rapid Diagnostic Tests (Rdts)
  • Other Infectious Disease Tests
  • 6.7. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Coagulation Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prothrombin Time (Pt) Testing Kits
  • International Normalized Ratio (Inr) Monitors
  • Activated Partial Thromboplastin Time (Aptt) Testing Kits
  • Coagulation Control Solutions
  • Whole Blood Coagulation Monitors
  • 6.8. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Pregnancy And Fertility Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Home Pregnancy Tests (Urine-Based)
  • Ovulation Prediction Kits
  • Pregnancy Test Strips
  • Fertility Monitoring Devices
  • 6.9. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Tumor Or Cancer Marker Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Psa (Prostate-specific Antigen) Testing Kits
  • Cea (Carcinoembryonic Antigen) Testing Kits
  • Ca-125 (Ovarian Cancer Marker) Kits
  • Her2 Testing Kits
  • Other Tumor Marker Test Kits
  • 6.10. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Cholesterol Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Total Cholesterol Testing Kits
  • Ldl Or Hdl Testing Kits
  • Triglyceride Testing Kits
  • Point-Of-Care Lipid Panel Devices
  • 6.11. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Hematology Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemoglobin Test Kits
  • Hematocrit Testing Kits
  • Complete Blood Count (Cbc) Kits
  • Point-Of-Care Hematology Analyzers
  • Hemoglobin A1c Testing Devices
  • 6.12. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Drug-Of-Abuse (Doa) Testing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine Drug Tests
  • Oral Fluid Drug Tests
  • Saliva-Based Drug Tests
  • Blood-Based Drug Tests
  • Breath Alcohol Tests
  • 6.13. Global Primary Care POC Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Allergy Testing Kits
  • Urinalysis Test Strips
  • Vitamin And Mineral Deficiency Testing Kits
  • Point-Of-Care Liver Function Tests
  • Kidney Function Testing Products
  • Blood Gas Testing Devices

7. Primary Care POC Diagnostics Market Regional And Country Analysis

  • 7.1. Global Primary Care POC Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Primary Care POC Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Primary Care POC Diagnostics Market

  • 8.1. Asia-Pacific Primary Care POC Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Primary Care POC Diagnostics Market

  • 9.1. China Primary Care POC Diagnostics Market Overview
  • 9.2. China Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Primary Care POC Diagnostics Market

  • 10.1. India Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Primary Care POC Diagnostics Market

  • 11.1. Japan Primary Care POC Diagnostics Market Overview
  • 11.2. Japan Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Primary Care POC Diagnostics Market

  • 12.1. Australia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Primary Care POC Diagnostics Market

  • 13.1. Indonesia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Primary Care POC Diagnostics Market

  • 14.1. South Korea Primary Care POC Diagnostics Market Overview
  • 14.2. South Korea Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Primary Care POC Diagnostics Market

  • 15.1. Western Europe Primary Care POC Diagnostics Market Overview
  • 15.2. Western Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Primary Care POC Diagnostics Market

  • 16.1. UK Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Primary Care POC Diagnostics Market

  • 17.1. Germany Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Primary Care POC Diagnostics Market

  • 18.1. France Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Primary Care POC Diagnostics Market

  • 19.1. Italy Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Primary Care POC Diagnostics Market

  • 20.1. Spain Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Primary Care POC Diagnostics Market

  • 21.1. Eastern Europe Primary Care POC Diagnostics Market Overview
  • 21.2. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Primary Care POC Diagnostics Market

  • 22.1. Russia Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Primary Care POC Diagnostics Market

  • 23.1. North America Primary Care POC Diagnostics Market Overview
  • 23.2. North America Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Primary Care POC Diagnostics Market

  • 24.1. USA Primary Care POC Diagnostics Market Overview
  • 24.2. USA Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Primary Care POC Diagnostics Market

  • 25.1. Canada Primary Care POC Diagnostics Market Overview
  • 25.2. Canada Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Primary Care POC Diagnostics Market

  • 26.1. South America Primary Care POC Diagnostics Market Overview
  • 26.2. South America Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Primary Care POC Diagnostics Market

  • 27.1. Brazil Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Primary Care POC Diagnostics Market

  • 28.1. Middle East Primary Care POC Diagnostics Market Overview
  • 28.2. Middle East Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Primary Care POC Diagnostics Market

  • 29.1. Africa Primary Care POC Diagnostics Market Overview
  • 29.2. Africa Primary Care POC Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Primary Care POC Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Primary Care POC Diagnostics Market Competitive Landscape
  • 30.2. Primary Care POC Diagnostics Market Company Profiles
    • 30.2.1. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton, Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. bioMerieux SA Overview, Products and Services, Strategy and Financial Analysis

31. Primary Care POC Diagnostics Market Other Major And Innovative Companies

  • 31.1. Quidel Corporation
  • 31.2. Sysmex Corporation
  • 31.3. Bio-Rad Laboratories Inc.
  • 31.4. Nova Biomedical Corporation
  • 31.5. Randox Laboratories Ltd
  • 31.6. Ortho Clinical Diagnostics
  • 31.7. Nipro Corporation
  • 31.8. OraSure Technologies
  • 31.9. Meridian Bioscience Inc
  • 31.10. DiaSorin SpA
  • 31.11. Sekisui Diagnostics LLC
  • 31.12. EKF Diagnostics Holdings plc
  • 31.13. Trinity Biotech plc
  • 31.14. Fujirebio Diagnostics Inc.
  • 31.15. Immunodiagnostic Systems Holdings PLC

32. Global Primary Care POC Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Primary Care POC Diagnostics Market

34. Recent Developments In The Primary Care POC Diagnostics Market

35. Primary Care POC Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Primary Care POC Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Primary Care POC Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Primary Care POC Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer